Honigman Adds to its Growth Efforts, Recruits Five Wall Street Attorneys to Build a Community of U.S. Lawyers in Israel
DETROIT–(BUSINESS WIRE)–In an innovative move to continue deepening its bench of sophisticated transactional attorneys, Honigman…
DETROIT–(BUSINESS WIRE)–In an innovative move to continue deepening its bench of sophisticated transactional attorneys, Honigman…
Extraction of 350+ unique entities of PXI corporate data categories reduce timescales from days to…
TORONTO–(BUSINESS WIRE)–#ArtificialIntelligence—Ecopia AI (“Ecopia”) today announced that it was awarded $10 million in contracts ($7.8M…
Experienced financial planner, renowned columnist and two-time author brings his aligned vision for deeper, more…
Company positioned to accelerate growth with recent acquisitions and investments in data and AI, unique…
With Rimini Street, SAP customers can drive value from existing ERP investments while assessing, implementing,…
Over 100% ARR year-over-year growth with net dollar retention rate exceeding 140% Record adoption by…
AUSTIN, Texas, Aug. 31, 2022 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing…
Positive findings from the RIVER study and data on retreatment with ILUVIEN available ATLANTA, Aug….
BOSTON, Aug. 31, 2022 (GLOBE NEWSWIRE) — AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused…
New designation may expedite FDA review and potential approval to address this life-threatening heart condition…
Dr. Stapleton has more than 20 years of industry experience leading technical, quality and manufacturing…
CINCINNATI, Aug. 31, 2022 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water…
Webcast to take place on September 27 at 8:00 a.m. ET, followed by live Q&A…
• TransCon PTH could, if approved, become the first hormone replacement therapy to address the…
MARLBOROUGH, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The…
AU ZH, Switzerland, Aug. 31, 2022 (GLOBE NEWSWIRE) — Araris Biotech AG, a company pioneering…
Myriad Genetics’ EndoPredict test accurately identified premenopausal women with ER+, HER2- breast cancer who could…
ZUG, Switzerland and CAMBRIDGE, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP),…
NEWARK, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) — Rain Therapeutics Inc. (NasdaqGS: RAIN), (“Rain”), a…